Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant IL2RA (Daclizumab Biosimilar) anticorps

Research Grade Reactivité: Humain ELISA Hôte: Mammalian Cells Monoclonal unconjugated Recombinant Antibody
N° du produit ABIN7487796
  • Antigène Tous les produits IL2RA (Daclizumab Biosimilar)
    IL2RA (Daclizumab Biosimilar)
    Type d'anticorp
    Recombinant Antibody
    Reactivité
    • 3
    • 2
    • 2
    Humain
    Hôte
    • 1
    • 1
    • 1
    Mammalian Cells
    Expression System
    Mammalian cells
    Clonalité
    • 2
    • 1
    Monoclonal
    Conjugué
    • 3
    Cet anticorp IL2RA (Daclizumab Biosimilar) est non-conjugé
    Application
    • 3
    • 3
    ELISA
    Fonction
    Daclizumab Biosimilar - Anti-IL2RA mAb
    Attributs du produit
    Antibody Type: IgG1-kappa
    Purification
    Recombinant antibody expressed in mammalien cells and purified.
    Classe de qualité
    Research Grade
    Isotype
    IgG1 kappa
  • Restrictions
    For Research Use only
  • Buffer
    PBS pH 7.5
    Stock
    -80 °C
    Stockage commentaire
    store at -80°C
  • Antigène
    IL2RA (Daclizumab Biosimilar)
    Abstract
    IL2RA (Daclizumab Biosimilar) Produits
    Synonymes
    anticorps CD25, anticorps IDDM10, anticorps IL2R, anticorps TCGFR, anticorps interleukin 2 receptor subunit alpha, anticorps IL2RA
    Classe de substances
    Biosimilar
    Sujet
    BIIB019,DAC HYP
    Daclizumab is a humanized IgG1 monoclonal antibody that binds to human interleukin 2 receptor (anti-Tac or anti-CD25)and composed of human >90%) and murine (10%) antibody sequences. The human sequence is derived from the constant domain of human IgG1 and the variable framework region of Eu myeloma antibody. The murine part was taken from the complementarity-determining regions of a murine anti-Tac antibody. Daclizumab has been used for preventing acute organ rejection in de novo allogeneic kidney transplantation when used simultaneously with immunosuppressive regimens such as cyclosporine and corticosteroid and in the treatment of adult patients with relapsing multiple sclerosis. These trademarks were Zenapax and Zimbryta, respectively.
    Numéro CAS
    152923-56-3
Vous êtes ici:
Support technique